Xiang Lu

Academic / Other · 1 registered clinical trial.

Status	Trial	Phase	Started
Unknown	Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcino Head and Neck Squamous Cell Carcinomas, Resectable Head and Neck Squamous-cell Carcinoma	Phase 2	2023-01-01